Please ensure Javascript is enabled for purposes of website accessibility
Now accepting applications for SPARK™ - Albireo’s Grants in Rare Liver Disease program. Learn more.

Alagille Syndrome

Alagille syndrome (ALGS) is a rare, multisystem genetic disorder that can affect the liver, heart, skeleton, eyes, central nervous system, kidneys and facial features. The estimated incidence of ALGS ranges from 1 in 30,000 to 50,000 live births. Liver damage is caused by a paucity of bile ducts preventing bile flow from the liver to the small intestine. Approximately 95% of patients with the condition present with chronic cholestasis, usually within the first three months of life, and as many as 88% also present with severe, intractable pruritus. Currently, there are no approved drug treatments.

To learn more about ALGS and find resources, visit the Alagille Syndrome Alliance.

This is not an exhaustive list of organizations. Albireo assumes no responsibility for information or statements on external websites.